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Abstract
In the last years, the evolution and the advances of the nanobiotechnologies 
applied to the systematic study of proteins, namely proteomics, both structural 
and functional, and specifically the development of more sophisticated and large-
scale protein arrays, have enabled scientists to investigate protein interactions and 
functions with an unforeseeable precision and wealth of details. Here, we present 
a further advancement of our previously introduced and described Nucleic Acid 
Programmable Protein Arrays (NAPPA)-based nanoconductometric sensor. 
We coupled Quartz Crystal Microbalance with Dissipation factor Monitoring 
(QCM_D) with piezoelectric inkjet printing technology (namely, the newly 
developed ActivePipette), which enables to significantly reduce the volume 
of probe required for genes/proteins arrays. We performed a negative control 
(with master mix, or MM) and a positive control (MM_p53 plus MDM2). We 
performed this experiment both in static and in flow, computing the apparent 
dissociation constant of p53-MDM2 complex (130 nM, in excellent agreement 
with the published literature). We compared the results obtained with the 
ActivePipette printing and dispensing technology vs. pin spotting. Without 
the ActivePipette, after MDM2 addition the shift in frequency (Δf ) was 7575 
Hz and the corresponding adsorbed mass was 32.9 µg. With the ActivePipette 
technology, after MDM2 addition Δf was 7740 Hz and the corresponding 
adsorbed mass was 33.6 µg. With this experiment, we confirmed the sensing 
potential of our device, being able to discriminate each gene and protein as well 
as their interactions, showing for each one of them a unique conductance curve. 
Moreover, we obtained a better yield with the ActivePipette technology, 
Keywords
Cell-free expression system, MDM2, Nanoconductometric sensor, 
NanoProbeAssay, Nucleic Acid Programmable Protein Array (NAPPA), p53, 
Piezoelectric inkjet printing, Quartz Crystal Microbalance with Dissipation 
factor Monitoring (QCM_D)
Introduction
In the last decades, the rapidly increasing evolution and the advances of 
the nanobiotechnologies applied to the systematic study of proteins, namely 
proteomics, both structural and functional, and specifically the development of 
more sophisticated and large-scale protein arrays [1], have enabled scientists to 
investigate protein interactions and functions with an unforeseeable precision and 
wealth of details [2]. Protein arrays are an important proteomics tool, together 
with mass spectrometry and 2-dimensional gel electrophoresis [3-6]. Moreover, 
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devices, namely QCM. QCM_D indeed appears a promising 
tool to study protein-protein interactions especially in the field 
of oncology, both cellular and molecular.
Inkjet printing confers more advantages: in the field 
of nanotechnologies, it has been exploited to produce a 
formulation capable of controlling the release of a drug [20], 
to better functionalize biosensors [21-24]. 
To the best of our knowledge, we coupled for the first 
time QCM_D with NAPPA technology and piezoelectric 
inkjet printing for biomedical applications. The objective of 
the present research regards the analysis of protein-protein 
interaction towards potentially useful clinical applications, 
namely in the field of cancer studies.
Clinical implications are also envisaged and addressed.
Materials and Methods 
QCM_D conductometer
Nanogravimetry makes use of functionalized piezoelectric 
quartz crystals (QC), which vary their resonance frequency (f) 
when a mass (m) is adsorbed to or desorbed from their surface. 
This is well described by the well-known Sauerbrey’s equation:
Δf = S ∙ Δm = – 2 ∙ f2/Zp ∙ Δm
where Δf is the frequency shift, Δm is the change of mass 
per area, S is the mass sensitivity, f is the resonant frequency, Zp 
is the acoustical impedance.
This equation can be expressed also as:
Δf/f0 = - m/(A ∙ ρ ∙ l)
where f0 is the fundamental frequency, A is the surface area 
covered by the adsorbed molecule and ρ and l are the quartz 
density and thickness, respectively. 
Quartz resonators response strictly depends on the 
biophysical properties of the analyte, such as the viscoelastic 
coefficient. The dissipation factor (D) of the crystal’s oscillation 
is correlated with the softness of the studied material and its 
measurement can be computed by taking into account the 
bandwidth of the conductance curve 2Γ, according to the 
following equation:
D = 2Γ/f 
where f is the peak frequency value. 
In our analysis we introduced also a “normalized D factor”, 
DN, that we defined as the ratio between the half-width half-
maximum (Γ) and the half value of the maximum value of the 
conductance (Gmax) of the measured conductance curves [11]:
DN = 2Γ/Gmax 
DN is more strictly related to the curve shape, reflecting 
the conductance variation [2, 11]. 
ActivePipette piezoelectric inkjet technology
For this experiment, we exploited a newly developed 
technology that enables to significantly reduce the volume 
of probe required for genes/proteins arrays [25-27]. This 
technology relies upon the precise, non-contact printing 
capabilities of a piezoelectric inkjet printer. When compared to 
so-called cell-free protein arrays [7, 8] can be coupled with 
label-free approaches: which offer unique advantages in the 
study of human proteome [9-11].
In this manuscript, we report and discuss some preliminary 
results of protein expression of genes related to cancer, coupling 
Nucleic Acid Programmable Protein Array (NAPPA) with a 
recently improved nanogravimetric apparatus which exploits 
the quartz crystal microbalance with frequency (QCM_F) 
and quartz crystal microbalance with dissipation monitoring 
(QCM_D) technologies [11, 12] and using a newly developed 
piezoelectric liquid dispensing technology. 
The selected proteins are p53 and MDM2 because of 
their importance and biological roles, which will be briefly 
summarized and reviewed in the following paragraphs. 
p53, as a nuclear transcription factor and oncosuppressor, 
plays a major role in the regulation of the cell cycle, DNA 
repair, and cell death/senescence/apoptosis, responding to 
DNA damage, hypoxia, oncogene activation and other kinds of 
stress. It finely tunes survival of proteins in the mitochondria, 
microRNA processing, and protein translation among the 
other biological processes in which it is involved [13]. Mouse 
double minute 2 homolog protein (MDM2) is one of the 
main p53 negative regulators since it acts as an E3 ubiquitin 
ligase that catalyzes the ubiquitination of p53 for degradation, 
recognizing the N-terminal trans-activation domain (TAD) of 
p53 [14]. Inhibitors that target p53, MDM2 or p53/MDM2 
interaction are an important class of anticancer therapeutics 
[14, 15].
At a molecular level, MDM2 has a deep binding pocket 
for p53, which is only 18 Å long but is fundamental for the 
interaction with p53’s Trp23, Leu26, and Phe19 (the so-called 
“three finger pharmacophore” model) [13].
We chose NAPPA since this innovative technology avoids 
any time-consuming task in the difficult process of obtaining 
highly purified proteins, relying instead on the production 
of proteins from high quality super-coiled DNA. For this 
purpose, complementary DNAs (cDNAs) of selected genes 
tagged with a C-terminal glutathione S-transferase (GST) 
are spotted on the microarray surface and expressed using 
a cell-free transcription/translation system (IVTT, in vitro 
transcription and translation). The newly expressed protein is 
captured on the array by an anti-GST antibody that have been 
co-immobilized with the expression clone on the microarray 
surface. 
The advantages and benefits of NAPPA technologies can 
be briefly summarized [11]: 
(1) The demanding and challenging process of obtaining 
highly purified proteins is replaced by a single quick step; 
furthermore, cDNAs and clones are more easily available; 
(2) Proteins expressed on the NAPPA arrays are stable, 
properly folded and biologically, functionally active. 
NAPPA microarrays can be useful in biomarkers 
discovery and for other clinical applications [16], such as 
biosensor development, especially in the effort of moving 
towards Personalized Medicine [17-19]. For this task we 
coupled NAPPA with a new generation of conductometric 
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pin spotters, it enables to avoid some drawbacks, such as slow 
printing and dispensing speed, satellite spots, ring-like stains or 
‘‘coffee mug’’ effects, inhomogeneous spots, misplaced or even 
absent spots due to evaporation issues and poorly controlled 
deposition and confinement, and spot contamination [27, 28]. 
Moreover, two important advantages of piezoelectric inkjet 
printing are the possibility of spotting on complex surfaces 
[27, 29] and using also clinical samples of limited volume and 
amount, thus showing more biotechnological and biomedical 
potential and implications.
 NAPPA experiments
The QCM_D instrument was developed by Elbatech 
(Elbatech srl, Marciana – LI, Italy). The quartz was connected 
to an RF gain-phase detector (Analog Devices, Inc., Norwood, 
MA, USA) and was driven by a precision DDS (Analog 
Devices, Inc., Norwood, MA, USA) around its resonance 
frequency, thus acquiring a conductance versus frequency 
curve (“conductance curve”) which shows a typical Gaussian 
behavior. The conductance curve peak was at the actual 
resonance frequency while the shape of the curve indicated 
how the viscoelastic effects of the surrounding layers affected 
the oscillation. The QCM_D software, QCMAgic-Q5.3.256 
(Elbatech srl, Marciana – LI, Italy) allows to acquire the 
conductance curve or the frequency and dissipation factor 
variation versus time. In order to have a stable control of 
the temperature, the experiments were conducted in a 
temperature chamber. Microarrays were produced on standard 
nanogravimetry quartz used as highly sensitive transducers. 
The QC expressing proteins consisted of 9.5 MHz, AT-cut 
quartz crystal of 14 mm blank diameter and 7.5 mm electrode 
diameter, produced by ICM (Oklahoma City, USA). The 
electrode material was 100Å Cr and 1000Å Au and the quartz 
was embedded into glass-like structures for easy handling [11, 
30]. 
The NAPPA-QC arrays were printed with 100 spots per 
QC.
Quartzes gold surfaces were coated with cysteamine to 
allow the immobilization of the NAPPA printing mix. Briefly, 
quartzes were washed three times with ethanol, dried with 
Argon and incubated over night at 4°C with 2 mM cysteamine. 
Quartzes were then washed three times with ethanol to remove 
any unbound cysteamine and dried with Argon. Plasmids 
DNA coding for GST tagged proteins were transformed 
into E. coli and DNA were purified using the NucleoPrepII 
anion exchange resin (Macherey Nagel). NAPPA printing 
mix was prepared with 1.4 µg/ul DNA, 3.75 µg/ul BSA 
(Sigma-Aldrich), 5mM BS3 (Pierce, Rockford, IL, USA) and 
66.5 µg polyclonal capture GST antibody (GE Healthcares). 
Negative controls, named master mix (hereinafter abbreviated 
as “MM”), were obtained replacing DNA for water in the 
printing mix. Samples were incubated at room temperature 
for 1 hour with agitation and then printed on the cysteamine-
coated gold quartz using the Qarray II from Genetix. In order 
to enhance the sensitivity, each quartz was printed with 100 
identical features of 300 microns diameter each, spaced by 350 
microns center-to-center. The human cDNAs immobilized on 
the NAPPA-QC were: p53 and MDM2.
Gene expression was performed immediately before 
the assay, following the protocol described in [11]. Briefly, 
IVTT was performed using HeLa lysate mix (1-Step Human 
Coupled IVTT Kit, Thermo Fisher Scientific Inc.), prepared 
according to the manufacturers’ instructions. The quartz, 
connected to the nanogravimeter inside the incubator, was 
incubated for 10 min at 30°C with 40 µl of HeLa lysate mix for 
proteins synthesis and then, the temperature was decreased to 
15°C for a period of 5 min to facilitate the proteins binding on 
the capture antibody (anti-GST). After the protein expression 
and capture, the quartz was removed from the instrument and 
washed at room temperature, in 500 mM NaCl PBS for 3 
times. The protocol described above was followed identically 
for both negative control QC (the one with only MM, i.e, 
all the NAPPA chemistry except the cDNA) and protein 
displaying QC.
After protein expression, capture, and washing the QCs 
were used for the interaction studies QC displaying the 
expressed protein was spotted with 40 µl of MDM2 at 22°C.
Reproducibility of the experiments was assessed 
computing the coefficient of variation (CV, or σ*), using the 
following equation: 
σ* = σ/µ, 
where σ is the standard deviation, and µ is the mean. 
We performed experiment both in static and in flow. 
This method enables to compute the apparent dissociation 
constant, using the following equation [31]:
Figure A: Piezoelectric liquid dispensing for printing and probing of 
NanoProbeArrays.
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where f(t) is the frequency at time t, t0 represents the start 
of dissociation, f0 is the frequency at t0, kdiss is the apparent 
dissociation rate constant.
Results and Discussion
QCM_D measures were calibrated for frequency and for 
D factor shifts. The calibration curves equation (obtained with 
Ordinary Least Squares methods, OLS) are: 
Δf= - 7.16 – 231.18 m; with r2= 0.9986, 
and: 
D = 0.831 + 0.286 η; with r2= 0.9990. 
Figure 1: Conductance curves of MM QC (upper). The curves were 
collected in different steps of NAPPA protocol, as reported in the legend.
Figure 2: Conductance curves of MM_p53 QC. The curves were collected 
in different steps of NAPPA protocol, as reported in the legend, and after 
MDM2 addition.
Figure 3: Flow interaction between p53 and MDM2 in solution.
We analyzed the conductance curves acquired in NAPPA-
QCs in different steps of the expressing and capturing process: 
after the addition of human IVTT lysate at 30°C (“IVTT 
addition”), i.e. prior protein expression; after the final washing 
process with PBS (“Post-wash”); after addition of the substrate.
In Figure 1 are reported the conductance curves of the 
negative control (MM experiment), while in Figure 2 are 
shown the conductance curves of quartz carrying p53 gene 
being expressed and thereafter interacting with MDM2 are 
reported. 
Figure 3 shows the same experiment of Figure 2 conducted 
in flow (frequency versus time, and D factor versus time). 
We computed the apparent dissociation constant of the 
p53-MDM2 complex 130 nM, which is in excellent agreement 
with the extant literature [32].






Beginning 9491920 5610 0,43 0,59 13001,16
IVTT addition 1 min 
30°C 9487615 10020 0,38 1,056 26382,31
IVTT addition 10 
min 30°C 9487615 10020 0,38 1,056 26458,94
IVTT addition 30 
min 30°C 9487510 9270 0,31 0,98 29626,08
IVTT addition 50 
min 15°C 9487450 7710 0,32 0,81 24329,44
After 120 min post 
PBS washing 22°C 9482245 12150 0,21 1,28 58923,38
aConductance curves were collected in different steps of NAPPA protocol. bf is peak 
frequency, Γ is the half-width half-maximum (HWHM), and Gmax is the maximum 
conductance. cD factor and DN (computed as DN = 2Γ/Gmax) normalized D factor.
Table 1: Main Parameters of QC-NAPPA Displaying MM 


















1 min 30°C 3,2 - - -4305 - 18,7 -
IVTT addition 
10 min 30°C 3,8 0 76,6 -4305 0 18,7 0
IVTT addition 
30 min 30°C 4,5 -0,08 3243,8 -4410 105 19,1 0,5
IVTT addition 
50 min 15°C 3,1 -0,24 -2052,9 -4470 165 19,4 0,7
aCoefficient of variation of three independent experiments. bD factor and 
normalized D factor shifts (ΔD and ΔDN) respect the values immediately after 
lysate addition cFrequency shifts respect the initial frequency (Δf ) and respect the 
frequency immediately after lysate addition (Δf ′) and corresponding molecular 
masses (m and m′).
Table 2: Shift of the Main Parameters of MM and p53 Conductance 
Curves after Lysate Addition and MDM2 addition, and the 
Corresponding Mass of Immobilized Protein on the QC Surface. 
In Tables 1-4, the main parameters of the conductance 
curves of Figure 1 and 2 are reported. 
In Table 5, we compared the results obtained with the 
piezoelectric inkjet printing and dispensing ActivePipette 
technology with the values yielded without [30]. We can see 
that without the ActivePipette, after expressing the protein 
and washing Δf was 4530 Hz and the corresponding adsorbed 
mass was 19,7 µg, while after MDM2 addition Δf was 7575 
Hz and the corresponding adsorbed mass was 32,9 µg.
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With the ActivePipette technology, after expressing the 
protein and washing Δf was 4665 Hz and the corresponding 
adsorbed mass was 20,3 µg, while after MDM2 addition Δf 
was 7740 Hz and the corresponding adsorbed mass was 33.6 
µg.






Beginning 9475375 5190 0,41 0,55 12795,86
IVTT addition 1 
min 30°C 9471055 8040 0,32 0,85 25267,13
IVTT addition 10 
min 30°C 9470950 8010 0,32 0,85 25348,1
IVTT addition 70 
min 30°C 9470710 7950 0,31 0,84 25546,27
IVTT addition 120 
min 15°C 9470710 7950 0,31 0,84 25546,27
After 120 min post 
PBS washing 9470710 7950 0,31 0,84 25546,27
MM_p53 plus MDM2
1 min 9467770 8460 0,14 0,89 62527,72
10 min 9467635 8220 0,14 0,87 60798,82
20 min 9467875 7140 0,15 0,75 49139,71
40 min 9468175 6570 0,14 0,69 45720,25
60 min 9468100 9000 0,13 0,95 67164,18
15 h 9470170 8190 0,27 0,86 30639,73
aConductance curves were collected in different steps of NAPPA protocol. bf is 
peak frequency, Γ is the half-width half-maximum (HWHM), and Gmax is 
the maximum conductance. cD factor and DN (computed as DN = 2Γ/Gmax) 
normalized D factor.




















1 min 30°C 3,2 - - -4320 - 18,8 -
IVTT addition 
10 min 30°C 4,2 -0,003 81 -4425 105 19,2 0,5
IVTT addition 
70 min 30°C 3,5 -0,01 279 -4665 345 20,3 1,5
IVTT addition 
120 min 15°C 4,1 -0,01 279 -4665 345 20,3 1,5
MM_p53 plus MDM2
1 min 3,8 0,04 37260,6 -7605 3285 33 14,3
10 min 4,1 0,02 35531,7 -7740 3420 33,6 14,9
20 min 3,5 -0,09 23872,6 -7500 3180 32,6 13,8
40 min 3,7 -0,16 20453 -7200 2880 31,3 12,5
60 min 4,2 0,1 41897 -7275 2955 31,6 12,8
15 h 4,1 0,02 5372,6 -5205 885 22,6 3,8
aCoefficient of variation of three independent experiments. bD factor and 
normalized D factor shifts (ΔD and ΔDN) respect the values immediately after 
lysate addition cFrequency shifts respect the initial frequency (Δf ) and respect the 
frequency immediately after lysate addition (Δf ′) and corresponding molecular 
masses (m and m′).
Table 4: Shift of the Main Parameters of MM and p53 Conductance 
Curves after Lysate Addition and MDM2 addition, and the 
Corresponding Mass of Immobilized Protein on the QC Surface. 
Conductance 
curves f(Hz)

















9470905 9470710 3705 7950 0,31 0,31 23903 25546
After MDM2 
addition 9467860 9467635 3600 8220 0,14 0,14 53333 60799
Table 5: Comparison between the MM_p53 plus MDM2 experiment 
carried out with the traditional technology (a) (published in Nicolini 
et al., 2012) and experiment with the ActivePipette piezoelectric inkjet 
dispensing technology (b). 
Conclusions
In this paper, we successfully introduced an advancement in 
our previously described NAPPA-based nanoconductometric 
sensor, coupling it with a newly developed piezoelectric 
inkjet printing and dispensing technology (namely, the 
ActivePipette). We performed a negative control (MM) and 
a positive control (MM_p53 plus MDM2). We confirmed the 
sensing potential of our device, being able to discriminate each 
gene and protein as well as their interactions, showing for each 
one of them a unique conductance curve. Moreover, in this 
communication, we showed that we obtained a better yield 
with ActivePipette piezoelectric dispensing technology.
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